This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, K. H. Articles by Westermark, P. Search for Related Content PubMed PubMed Citation Articles by Johnson, K. H. Articles by Westermark, P.

American Journal of Pathology, Vol 141, 1013-1019, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Pulmonary vascular amyloidosis in aged dogs. A new form of spontaneously occurring amyloidosis derived from apolipoprotein AI

KH Johnson, K Sletten, DW Hayden, TD O'Brien, KE Roertgen and P Westermark
Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul 55108.

The N-terminus of a mutant form of apolipoprotein AI [apoAI] has previously been shown to be the subunit protein of amyloid fibrils in a human kindred with a form of familial amyloid polyneuropathy (FAP, type III) and in a recently reported kindred with a form of non-neuropathic hereditary amyloidosis. In this study, we demonstrate by amino-acid sequence analysis, that a form of vascular amyloidosis occurring in the lungs of aged dogs is derived from a N-terminal fragment of apoAI and that no amino acid substitution is present in this confirmed sequence. This represents the first documentation of apoAI as a precursor for a form of amyloidosis in animals, and provides the first documentation of apoAI as a precursor for amyloid fibrils in a form of age-associated ("senile") amyloidosis. Secondary structure prediction analysis of the N-terminal regions of normal human and dog apoAI indicated a propensity for beta-pleated sheet conformation, and thus amyloidogenesis, in 40 and 45% of the respective sequences. These results suggest that apoAI (like transthyretin) may serve as an amyloid precursor protein for both familial and senile forms of amyloidosis. ApoAI should, therefore, be considered as a potential amyloid precursor when forms of human senile amyloidosis of unknown origin are evaluated.

This article has been cited by other articles:

				I Kholova and H W M Niessen Amyloid in the cardiovascular system: a review J. Clin. Pathol., February 1, 2005; 58(2): 125 - 133. [Abstract] [Full Text] [PDF]

				A. Andreola, V. Bellotti, S. Giorgetti, P. Mangione, L. Obici, M. Stoppini, J. Torres, E. Monzani, G. Merlini, and M. Sunde Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I J. Biol. Chem., January 17, 2003; 278(4): 2444 - 2451. [Abstract] [Full Text] [PDF]

				P. Mangione, M. Sunde, S. Giorgetti, M. Stoppini, G. Esposito, L. Gianelli, L. Obici, L. Asti, A. Andreola, P. Viglino, et al. Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure Protein Sci., January 1, 2001; 10(1): 187 - 199. [Abstract] [Full Text]

				L. Obici, V. Bellotti, P. Mangione, M. Stoppini, E. Arbustini, L. Verga, I. Zorzoli, E. Anesi, G. Zanotti, C. Campana, et al. The New Apolipoprotein A-I Variant Leu174 -> Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal Polypeptide Am. J. Pathol., September 1, 1999; 155(3): 695 - 702. [Abstract] [Full Text] [PDF]

				L. Hamidi Asl, J. J. Liepnieks, K. Hamidi Asl, T. Uemichi, G. Moulin, E. Desjoyaux, R. Loire, M. Delpech, G. Grateau, and M. D. Benson Hereditary Amyloid Cardiomyopathy Caused by a Variant Apolipoprotein A1 Am. J. Pathol., January 1, 1999; 154(1): 221 - 227. [Abstract] [Full Text] [PDF]